Description

Laferobion Lyophilisate for Solution for Injections 1 ml. №10 Vial

Ingredients:

Each vial contains: Interferon alfa-2b (recombinant human interferon alpha-2b) 100,000 IU.

Mechanism of Action:

Interferon alfa-2b exerts its therapeutic effects through potent antiviral and antiproliferative actions. By modulating the immune response, it aids in combating viral infections and inhibiting the growth of cancer cells.

Pharmacological Properties:

Laferobion contains interferon alfa-2b, which is a recombinant human interferon alpha-2b. It demonstrates immunomodulatory and antiviral properties, contributing to its efficacy in treating viral infections and certain malignancies.

Indications for Use:

Laferobion is indicated for:

• Treatment of hepatitis B and C infections
• Management of genital warts
• Therapy for certain types of leukemia

Contraindications:

Avoid using Laferobion:

• In cases of hypersensitivity to interferon alfa-2b or any other component of the product
• In patients with autoimmune hepatitis

Side Effects:

Common side effects of Laferobion may include flu-like symptoms, fatigue, and injection site reactions. Monitoring for more severe adverse effects is essential during treatment.

Usage Instructions:

Preparation and Administration: The solution should be prepared as per the provided instructions and administered via intramuscular or subcutaneous injection. Adherence to aseptic techniques is crucial for safe use.

Benefits Compared to Analogues:

Laferobion offers the advantage of targeted therapy for viral infections and malignancies with its specific mechanism of action, potentially leading to improved treatment outcomes compared to traditional therapies.

Suitable Patient Groups:

Laferobion can be used in various patient populations, including adults, children, and the elderly. Dosage adjustments may be necessary based on individual patient characteristics and medical conditions.

Storage and Shelf Life:

Store Laferobion as per the recommended conditions on the packaging. Ensure proper storage temperature and protection from light to maintain the product’s stability. Check the expiration date before use.

Packaging Description:

Laferobion is available in vials containing lyophilized powder for reconstitution. Each package includes 10 vials, with clear labeling of the product name, dosage strength, and manufacturer information.

Clinical Evidence and Proven Effectiveness:

Studies have demonstrated the efficacy of interferon alfa-2b in improving viral clearance rates and halting the progression of certain malignancies. Clinical trials support the use of Laferobion in the treatment of viral infections and specific types of cancer.